Vervaet C - Search Results

1

Optimization of the processing of matrix pellets based on the combination of waxes and starch using experimental design.

Zhou F, Vervaet C, Massart DL, Massart B, Remon JP. Zhou F, et al. Among authors: vervaet c. Drug Dev Ind Pharm. 1998 Apr;24(4):353-8. doi: 10.3109/03639049809085630. Drug Dev Ind Pharm. 1998. PMID: 9876595

2

Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer.

Vervaet C, Remon JP. Vervaet C, et al. Pharm Res. 1997 Nov;14(11):1644-6. doi: 10.1023/a:1012151006742. Pharm Res. 1997. PMID: 9434288 No abstract available.

3

Characterization and evaluation of isomalt performance in direct compression.

Ndindayino F, Henrist D, Kiekens F, Vervaet C, Remon JP. Ndindayino F, et al. Among authors: vervaet c. Int J Pharm. 1999 Oct 28;189(1):113-24. doi: 10.1016/s0378-5173(99)00241-0. Int J Pharm. 1999. PMID: 10518691

4

Pharmacokinetics of florfenicol after treatment of pigs with single oral or intramuscular doses or with medicated feed for three days.

Voorspoels J, D'Haese E, De Craene BA, Vervaet C, De Riemaecker D, Deprez P, Nelis H, Remon JP. Voorspoels J, et al. Among authors: vervaet c. Vet Rec. 1999 Oct 2;145(14):397-9. doi: 10.1136/vr.145.14.397. Vet Rec. 1999. PMID: 10574273

5

Matrix mini-tablets based on starch/microcrystalline wax mixtures.

De Brabander C, Vervaet C, Fiermans L, Remon JP. De Brabander C, et al. Among authors: vervaet c. Int J Pharm. 2000 Apr 20;199(2):195-203. doi: 10.1016/s0378-5173(00)00383-5. Int J Pharm. 2000. PMID: 10802413

6

A validated HPLC method for the determination of thiazinamium methylsulphate in pharmaceutical preparations.

Smet E, Baeyens WR, Van der Weken G, Kiekens F, Vervaet C, Remon JP. Smet E, et al. Among authors: vervaet c. J Pharm Biomed Anal. 2000 Aug 1;23(1):175-83. doi: 10.1016/s0731-7085(00)00267-3. J Pharm Biomed Anal. 2000. PMID: 10898168

7

Bioavailability of ibuprofen from matrix mini-tablets based on a mixture of starch and microcrystalline wax.

De Brabander C, Vervaet C, Görtz JP, Remon JP, Berlo JA. De Brabander C, et al. Among authors: vervaet c. Int J Pharm. 2000 Nov 4;208(1-2):81-6. doi: 10.1016/s0378-5173(00)00549-4. Int J Pharm. 2000. PMID: 11203270 Clinical Trial.

8

An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen.

Vergote GJ, Vervaet C, Van Driessche I, Hoste S, De Smedt S, Demeester J, Jain RA, Ruddy S, Remon JP. Vergote GJ, et al. Among authors: vervaet c. Int J Pharm. 2001 May 21;219(1-2):81-7. doi: 10.1016/s0378-5173(01)00628-7. Int J Pharm. 2001. PMID: 11337168

9

Characterisation and disintegration properties of irradiated starch.

De Kerf M, Mondelaers W, Lahorte P, Vervaet C, Remon JP. De Kerf M, et al. Among authors: vervaet c. Int J Pharm. 2001 Jun 19;221(1-2):69-76. doi: 10.1016/s0378-5173(01)00655-x. Int J Pharm. 2001. PMID: 11397568

10

Cold extrusion as a continuous single-step granulation and tabletting process.

Keleb EI, Vermeire A, Vervaet C, Remon JP. Keleb EI, et al. Among authors: vervaet c. Eur J Pharm Biopharm. 2001 Nov;52(3):359-68. doi: 10.1016/s0939-6411(01)00195-3. Eur J Pharm Biopharm. 2001. PMID: 11677078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters